Fundraising

Viola Ventures rakes in over $170 mln for fifth fund

Viola Ventures, formerly known as Carmel Ventures, has raised over $170 million toward its fifth fund. The target is $200 million. The fund will invest in Israeli or Israeli-related early stage companies.

Brighteye Ventures wraps up inaugural fund

Brighteye Ventures, a European edtech-focused venture firm, has closed its debut fund at 50 million euros. The fund will lead or participate in Series A or B rounds for edtech companies; it will also consider making acquisitions. Brighteye Venture Advisers is the fund's adviser.

Frazier Healthcare Partners raises $419 mln for early-stage life science deals

Frazier Healthcare Partners announced the close of an oversubscribed Frazier Life Sciences IX, its second dedicated life sciences fund, with nearly $419 million in commitments. Led by Managing General Partners Patrick Heron and Jamie Topper, the Frazier life sciences team invests primarily in therapeutics-focused companies developing biopharmaceuticals, with two-thirds of the fund fueling seed and Series A rounds. Exits from 2017 include AnaptysBio (IPO) and Alpine Immune Sciences (reverse merger).

Fund performance: Bain Capital Ventures, DFJ top emerging venture portfolio

Tech and healthcare VCs work together in a new boardroom dynamic

Alsop Louie to raise a $125 mln fourth venture fund

Alsop Louie Partners has set out to raise a $125 million fourth venture fund, according to a filing with the SEC.

Klingenstein Fields to raise $50 mln for venture fund

Klingenstein Fields Wealth Advisors is seeking to raise $50 million for a venture fund, according to an SEC filing. The New York City-based firm provides financial and investment advice.

CircleUp creates CircleUp Growth Partners, raises $125 mln fund

San Francisco-based CircleUp, which operates an investment marketplace focused on early-stage consumer brands, announced today it raised a $125 million fund, CircleUp Growth Partners, which closed at 25 percent above its $100 million target. The firm, led by Managing Directors Alison Ryu and Ben Lee, will use the funds to invest in consumer brands, via a machine-learning platform it developed, called Helio.

Investment platform CircleUp raises $125 mln to target consumer brands

BioGeneration Ventures Fund III raises $95.3 mln

BioGeneration Ventures said Oct. 31 that it closed its third fund with 82 million euros ($95.3 million) in funding, exceeding its 50 million euro ($58.1 million) target. New investors include Bristol-Myers Squibb, Johnson & Johnson Innovation – JJDC Inc, as well as Schroder Adveq, and the MAN Pension Trust. BGV III will focus on seed investments in European biotechnology companies.